Cilostazol is a phosphodiesterase III inhibitor classified as an antiplatelet agent, primarily prescribed to improve blood flow and manage the symptoms of intermittent claudication associated with peripheral… Read more

![Chemical structure of 1-Cyclohexyl-1,5,6,7-tetrahydrotetrazolo[1,5-a]pyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-Cyclohexyl-1567-tetrahydrotetrazolo15-apyridine.png&w=3840&q=75)
![Chemical structure of 2-Amino-5-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]benzenepropanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1797509-92-2-2-Amino-5-4-1-cyclohexyl-1H-tetrazol-5-ylbutoxybenzenepropanoic-acid.png&w=3840&q=75)


















![Chemical structure of 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F865792-18-3-6-4-1-Cyclohexyl-1H-tetrazol-5-ylbutoxy-1-4-1-cyclohexyl-1H-tetrazol-5-ylbutyl-34-dihydro-21H-quinolinone.png&w=3840&q=75)




























Cilostazol is a phosphodiesterase III inhibitor classified as an antiplatelet agent, primarily prescribed to improve blood flow and manage the symptoms of intermittent claudication associated with peripheral vascular disease. Our catalogue for this category provides high-quality reference standards essential for comprehensive pharmaceutical analysis. Laboratories utilize these materials for impurity profiling, allowing for the precise identification and quantification of process-related impurities, degradation products, and specific metabolites such as OPC-3930. Furthermore, we offer stable isotope-labelled compounds, which serve as critical internal standards for accurate mass spectrometry and method validation in quality control testing. By incorporating these pharmacopeial and non-pharmacopeial reference materials into their workflows, researchers ensure rigorous regulatory compliance and consistency throughout the drug development and manufacturing lifecycle of this cardiovascular therapy.